Nicole C. Murphy

Head of Pharmaceutical Operations and TechnologyatBiogen· In proxies 2022–2025

Pay in FY2025+32% from the year before · Biogen stock +15.1% the same year

Nicole C. Murphy was paid $7.6M in FY2025 (Dec), up 32%. Biogen stock rose 15.1% that year.

Pay$100 in the stock at the end of FY21 → $73

Pay is from the Summary Compensation Table of each Biogen proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

BiogenPublic company · 4 yr
- Head of Pharmaceutical Operations and Technology2022 – Present · 4 yrStock in role +4%

Roles come from the proxy statements of each company.

Activity

Pay
Biogen Division head pay rose 32% to $7.6M. The stock rose 15% in FY2025 (Dec).
DEF 14AApr 28, 2026
Pay
Biogen Division head pay rose 16% to $5.7M. The stock fell 7% in FY2023 (Dec).
DEF 14AApr 28, 2025

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?